Toll-like receptors 3, 4 and 9 in hepatocellular carcinoma: Relationship with clinicopathological characteristics and prognosis.

@article{Eir2014TolllikeR3,
  title={Toll-like receptors 3, 4 and 9 in hepatocellular carcinoma: Relationship with clinicopathological characteristics and prognosis.},
  author={Noem{\'i} Eir{\'o} and Antonio Altadill and Luis Miguel Ju{\'a}rez and Manuel Rodr{\'i}guez and Luis Ovidio Gonz{\'a}lez and Sara Fern{\'a}ndez Atienza and Sandra Milena Cubillos Berm{\'u}dez and Bel{\'e}n Fern{\'a}ndez-Garc{\'i}a and Manuel Florentino Fresno-Forcelledo and Luis Rodrigo and Francisco J Vizoso},
  journal={Hepatology research : the official journal of the Japan Society of Hepatology},
  year={2014},
  volume={44 7},
  pages={
          769-78
        }
}
AIM Hepatocellular carcinoma (HCC) is in the 10 leading cancer types, being difficult to detect as most of patients who develop this tumor have no symptoms other than those related to their long-standing liver disease. The liver is constantly exposed to bacterial products, viral infection, alcohol or other products, which may be the cause of chronic liver damage, and thus an increasing risk for HCC. Toll-like receptors (TLR) have gained an extraordinary interest in cancer research due to their… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 29 CITATIONS

Toll-like receptor 2 and Toll-like receptor 4 predict favorable prognosis in local pancreatic cancer.

  • Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
  • 2018